TERESA GONGORA-GARCIA: Open Payments
NPI 1770805699 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,448 in 156 payments from 28 companies in 2025. Trend: 2023 $2,727 · 2024 $2,885 · 2025 $3,448
Food & beverage: $3,448
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $581 |
| AstraZeneca Pharmaceuticals LP | 18 | $472 |
| SHIELD THERAPEUTICS INC | 3 | $345 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $251 |
| Novartis Pharmaceuticals Corporation | 12 | $240 |
| Novo Nordisk Inc | 11 | $179 |
| ABBVIE INC. | 14 | $172 |
| Lilly USA, LLC | 8 | $156 |
| Exact Sciences Corporation | 5 | $109 |
| SANOFI-AVENTIS U.S. LLC | 5 | $104 |
Products named: ACCRUFER, Kerendia, LEQVIO, REPATHA, OTEZLA, FARXIGA, BREZTRI, KRYSTEXXA.
Industry payments across FL — which companies pay providers there.
